| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_907a8e0e35eed6fba0da0b1c70a8cdf3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
1999-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5faf1a6bb10cda6bfaea75b145d41bbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e44fccec32a6ccf4ae979d54193fde67 |
| publicationDate |
2001-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1140207-A1 |
| titleOfInvention |
Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| abstract |
The invention concerns a mammalian cell preparation optionally transfected with at least a gene coding for an active substance capable of being administered to a subject by systemic administration. The invention is characterised in that it does not comprise aggregate of said cells having a size likely to cause temporary or permanent dysfunction in the subject. The invention also concerns pharmaceutical compositions comprising said preparation and an acceptable carrier. |
| priorityDate |
1998-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |